Invasive Streptococcus pneumoniae infections: Serotype distribution and antimicrobial resistance in Canada, 1992-1995

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 3, 1998, Pages 327-331

  Lovgren, Marguerite ^a,c   Spika, John S ^b   Talbot, James A ^a  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G; STREPTOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ISOLATION; BLOOD; CEREBROSPINAL FLUID; CHILD; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0032502010     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumanise infections among children in Connecticut. J Infect Dis 1994;169:212-4.
2. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
3. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-5.
4. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina a decade later. Arch Intern Med 1990;150:1401-5.
5. Chesney PJ. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am J Dis Child 1992;146:912-6,
6. Klugman KP, Koornhof HJ. Drug resistance patterns and serogroups or serotype of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infret Dis 1988;158:956-64.
7. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
8. George RC, Ball LC, Cooper PG. Antibiotic-resistant pneumococci in the United Kingdom. Commun Dis Rep CDR Rev 1992;2:R37-43.
9. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
10. Leggiadro RJ. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: an emerging microbial threat. Pediatrics 1994;93:500-3.
11. Fenoll A, Bourgon CM, Munoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
12. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991; 163:1273-8.
13. Streptococcus pneumoniae with reduced susceptibility to penicillin G - Quebec. Can Dis Wkly Rep 1994;20:69-73.
14. Friedland IR, Shelton S, Paris M, Rinderknecht S, Ehrett S, Krisher K, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Ifect Dis J 1993;12:196-200.
15. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliot JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
16. Loo VG, Lavellee J, McAlear D, Robson HG. The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones. J Antimicrob Chemother 1994;33:641-5.
17. Simor AE, Rachlis A, Louie L, Goodfellow J, Louie M. Emergence of penicillin-resistant Streptococcus pneumoniae in southern Ontario, 1993-94. Can J Infect Dis 1995;6:157-60.
18. Simor AE, Louie M, Canadian Bacterial Surveillance Network, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996;40:2190-3.
19. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33:2759-62.
20. Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, et ai. Considerations for formulating the second-generation pneumococcal capsuiar poivsaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.
21. Neilsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 1992;15:794-8.
22. Sniadack DH, Schwanz B, Lipman H, Bogaerts J, ButlerJC, Dagan R, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile sire pneumococcal isolates from children - implications for vaccine strategies. Pediatr Infect Dis J 1995;14:503-10.
23. Facklam RR, Washington JA II. Streptococcus and related catalase-negative gram-positive cocci. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology. 5th ed. Washington: American Society for Microbiology; 1991. p. 238-57.
24. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved standard. Document M2-A5. Villanova (PA): The Committee; 1993.
25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard. Document M7-A3. Villanova (PA): The Committee; 1993.
26. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
27. Jette LP, Ringuette L, Dascal A, Lapointe J. Pneumococcal resistance to antimicrobial agents in the province of Quebec, Canada. J Clin Microbiol 1994;32:2572-5.
28. Lefevre JC, Bertrand MA, Faucon G. Molecular analysis by pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France. Ear J Clin Microbiol Infect Dis 1996;14:491-7.
29. Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302-6.
30. Survey of anrimicrobial susceptibility of community isolates of Streptococcus pneumoniae in Ontario. Can Dis Wkly Rep 1989;15:131-3.
31. Doern GV, Bnieggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimirob Agents Chemotber 1996;40:1208-13.
32. Butler JC:, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. JAMA 1993;270:1826-31.
33. Increasing pneumococcal vaccination rates among patients of a national health-care alliance - United States, 1993. MMWR 1995;44:741-4.
34. Fedson DS. Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: What can the two countries learn from each other? Clin Infect Dis 1995;20:1371-6.
35. Ross I. MDs short of pneumonia vaccine. Glove and Mail [Toronto] 1996 Nov 4; Sect A:3.